Apr 24, 2020
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
Mar 19, 2020
AGC Biologics to Participate in Virtual BIO-Europe Spring
Mar 04, 2020
AGC Biologics to Participate in DCAT Week
Feb 04, 2020
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases
Dec 11, 2019
AGC Biologics Expands Plasmid DNA Offering
Nov 12, 2019
AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint
Oct 01, 2019
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations
Jun 04, 2019
AGC Biologics Appoints New Chief Technical Officer
Apr 02, 2019
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019
Jan 07, 2019
AGC Biologics Announces Change in Executive Leadership
Dec 18, 2018
AGC Triples U.S. Biopharmaceutical Production Capacity
Aug 22, 2018
AGC Biologics Expands Capacity at Copenhagen, Denmark Facility
Jul 24, 2018
AGC Biologics Inaugurates New Global Headquarters Facility in Bothell, WA
May 30, 2018
AGC Biologics to Participate in Boston's BIO International Convention
May 24, 2018
AGC Biologics Cleared for Commercial Manufacture of Portola's FDA-Approved Andexxa®
May 10, 2018
AGC Biologics enters into Commercial Supply Agreement with MacroGenics
May 03, 2018
AGC Biologics Enters into Commercial Manufacturing Agreement with Horizon Pharma plc
Apr 12, 2018
AGC Biologics Appoints New Site Head/General Manager of Bothell, WA Operations
Mar 29, 2018
AGC Biologics Increases Footprint in Bothell, WA
Mar 13, 2018
AGC Biologics Appoints Two New Sr. Vice Presidents of Business Development